Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Anadys, Structural GenomiX Form Antibacterials Alliance

Feb. 21, 2002

By Aaron Lorenzo

Cytyc Acquiring Digene In Stock, Cash Deal Worth $554M

Feb. 20, 2002

By Aaron Lorenzo

Cytyc Acquiring Digene In Stock, Cash Deal Worth $554M

Feb. 20, 2002

By Aaron Lorenzo

Norak Closes Series B, Raises $13M For Screening Platform

Feb. 7, 2002

By Aaron Lorenzo

Chiron Licenses TB Product To Public-Private Partnership

Feb. 4, 2002

By Aaron Lorenzo

Biogen, Genaissance Align In Pharmacogenomics Area

Feb. 4, 2002

By Aaron Lorenzo

Biogen, Genaissance Align In Pharmacogenomics Area

Feb. 4, 2002

By Aaron Lorenzo

Chiron Licenses TB Product To Public-Private Partnership

Feb. 4, 2002

By Aaron Lorenzo

Intradigm, DirectGene Team Up To Develop Cancer Therapeutics

Jan. 28, 2002

By Aaron Lorenzo

Intradigm, DirectGene Team Up To Develop Cancer Therapeutics

Jan. 28, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...